Cargando…
Effect of high-dose ulinastatin on the cardiopulmonary bypass-induced inflammatory response in patients undergoing open-heart surgery
Autores principales: | Liu, Yu, Wang, Ying-Lin, Zou, Shao-Hua, Sun, Peng-Fei, Zhao, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339317/ https://www.ncbi.nlm.nih.gov/pubmed/32496303 http://dx.doi.org/10.1097/CM9.0000000000000832 |
Ejemplares similares
-
High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study
por: Rhee, Ka-Young, et al.
Publicado: (2018) -
Effects of Ulinastatin on Postoperative Blood Loss and Hemostasis in Atrioventricular Valve Surgery with Cardiopulmonary Bypass
por: Park, Jae Bum, et al.
Publicado: (2013) -
Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
por: Qiu, Yan, et al.
Publicado: (2015) -
Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass
por: Oh, Se-young, et al.
Publicado: (2012) -
Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
por: Wang, Xiaocou, et al.
Publicado: (2015)